Comparison of four automated prostate-specific antigen assays for detection of recurrence after radical prostatectomy

Urology

Volumn 49, Issue 6, 1997, Pages 894-897

  Sanders, Holt ^a   Graham Jr , Sam D ^a  

^a University School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REGRESSION ANALYSIS;

EQUIPMENT AND SUPPLIES; HUMANS; IMMUNOENZYME TECHNIQUES; LINEAR MODELS; MALE; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 0030912678     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00090-3     Document Type: Article

References (20)

1. Stamey TA, Kabalin JN, McNeal JE, Johnstone IM, Freiha F, Redwine EA, Yang N. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J Urol. 141:1989;1076-1083.
2. Oefelein MG, Smith N, Carter M, Dalton D, Schaeffer A. The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies. J Urol. 154:1995;2128.
3. Sanders WH, Cooner WH, Woodward M, Graham SD. Detection of local recurrence after radical prostatectomy. J Urol. 153:1995;518A.
4. Brawer MK, Daum P, Petteway JC, Wener MH. Assay variability in serum prostate-specific antigen determination. Prostate. 27:1995;1.
5. Vessella RL, Lange PH. Issues in the assessment of PSA immunoassays. Urol Clin North Am. 20:1993;607.
6. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin. 45:1995;8.
7. Erratum CA Cancer J Clin. 45:1995;127.
8. Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ confined prostate cancer is increased through prostate specific antigen-based screening. JAMA. 270:1993;948.
9. Takayama TK, Lange PH. Radiation therapy for local recurrence of prostate cancer after radical prostatectomy. Urol Clin North Am. 21:1994;687.
10. Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh PC. Serum PSA after anatomic radical prostatectomy. Urol Clin North Am. 20:1993;713.
11. Lange PH, Lightner DJ, Medini E, Reddy PK, Vessella RL. The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. J Urol. 144:1990;927.
12. Prestigiacomo AF, Stamey TA. A comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy. J Urol. 152:1994;1515.
13. Schambeck CM, Schmeller N, Stieber P, Jansen H-M, Pahl H, Schneider W, Fateh-Moghadam A. Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancer. Urology. 46:1995;195.
14. Graves HCB, Wehner N, Stamey TA. Comparison of polyclonal and monoclonal immunoassay for PSA: need for an international antigen standard. J Urol. 144:1990;1516.
15. Cattini R, Robinson D, Gill O, Jolley N, Bacarese-Hamilton T. Measurement of prostate-specific antigen in serum using four different immunoassays. Eur J Clin Chem Clin Biochem. 32:1994;181.
16. Lilja H. Significance of different molecular forms of serum PSA: the free, noncomplexed form of PSA versus that complexed to alpha-1-antichymotrypsin. Urol Clin North Am. 20:1993;681.
17. Stamey TA, Chen Z, Prestigiacomo A. Serum prostate specific antigen binding alpha-1-antichymotrypsin: influence of cancer volume, location and therapeutic selection of resistant clones. J Urol. 152:1994;1510.
18. Zhou AM, Tewari PC, Bluestein BI, Caldwell GW, Larsen FL. Multiple forms of prostate-specific antigen in serum: differences in immunorecognition by monoclonal and polyclonal assays. Clin Chem. 39:1993;2483.
19. Stamey TA, Graves HC, Wehner N, Ferrari M, Freiha FS. Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen. J Urol. 149:1993;787.
20. Yu H, Diamandis EP. Ultrasensitive time-resolved immunofluorometric assay for prostate-specific antigen in serum and preliminary clinical studies. Clin Chem. 39:1993;2108.